PeptideDB

Linaprazan glurate

CAS No.: 1228559-81-6

Linaprazan glurate inhibits exogenously or endogenously stimulated gastric acid secretion. Linaprazan glurate can be use
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Linaprazan glurate inhibits exogenously or endogenously stimulated gastric acid secretion. Linaprazan glurate can be used in studies about gastrointestinal inflammatory diseases and peptic ulcer diseases.
molecular weight 480.56
Molecular formula C26H32N4O5
CAS 1228559-81-6
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility DMSO: 4.37 mg/mL (9.09 mM)
References 1. Mikael Dahlström, et al. Imidazopyridine derivatives which inhibit the secretion of gastric acid. Patent WO2010063876A1.